Gene therapy progress and prospects: Parkinson's disease.
about
Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic AcidA synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseHuman gene therapy and imaging in neurological diseases.Combinatorial evaluation of cations, pH-sensitive and hydrophobic moieties for polymeric vector designNeuronal expression of the transcription factor Gli1 using the Talpha1 alpha-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease.Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model.Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease modelDopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease.Development and application of replication-incompetent HSV-1-based vectors.Antioxidant and astroprotective effects of a Pulicaria incisa infusion.Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.New non-oral drug delivery systems for Parkinson's disease treatment.Protective and antioxidant effects of a chalconoid from Pulicaria incisa on brain astrocytes.Regulated neuronal neuromodulation via spinal cord expression of the gene for the inwardly rectifying potassium channel 2.1 (Kir2.1).Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles.Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase.An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.Transfection of mammalian cells using block copolypeptide vesicles.
P2860
Q26774462-43A9FD86-D739-4629-A1EC-77D2415D8224Q28830946-9C2AFA5E-4A3E-4E86-904D-6E04A430ABDDQ31023442-FDBC0CFB-5FDA-4E4E-B66D-99BE7C61D10CQ33399696-E6B11F4E-F387-46E9-8861-251D8EED2C97Q34074765-454E723E-010F-4E04-90BD-DF120387F9C4Q34423923-E7D0CC94-4927-40DA-8C4F-B8B790795B3DQ34684014-95881CE9-60AF-4F03-9066-2184461847F3Q36040166-4DADE474-6445-4C74-9802-FFF6532313E8Q36151216-8656DAC5-D527-4D6B-8A35-DFFF7B4DB380Q36288938-D1E4265A-0A70-4C60-949A-B2C3B20E2833Q36520876-5171C675-FF53-4352-A50A-04F81821C19BQ36960666-D962F19E-EB6A-4DB8-8EDD-A47DA3604674Q37840165-B60113F3-958C-46DE-9818-9329BDDBF13BQ38992158-41E93ADF-ECB1-46F7-ABCB-A08DA3AC6474Q39218433-500CE668-EAE5-4A93-B11C-BDD5F63BFA62Q40268859-8125CAEB-5F8C-4300-96E7-837D8B509E57Q43211527-52224B77-B231-4EDE-8918-5DF01D337FC7Q43865449-878A1FFC-09D2-44EB-9FB0-3913AA52890BQ44174512-0CDC8D08-A297-4328-8076-EA29D1016FD0
P2860
Gene therapy progress and prospects: Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy progress and prospects: Parkinson's disease.
@ast
Gene therapy progress and prospects: Parkinson's disease.
@en
type
label
Gene therapy progress and prospects: Parkinson's disease.
@ast
Gene therapy progress and prospects: Parkinson's disease.
@en
prefLabel
Gene therapy progress and prospects: Parkinson's disease.
@ast
Gene therapy progress and prospects: Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Gene therapy progress and prospects: Parkinson's disease.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302116
P577
2003-09-01T00:00:00Z